Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 9, 2020HaematologicaOpen Access

Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJulia García-ReyeroUniversidad de CantabriaNMNerea Martı́nezUniversidad de GranadaSVSonia González de VillambrosíaMarqués de Valdecilla University Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

García-Reyero et al. (2020) studied this question.

synapsesocial.com/papers/6a7e13aa7981bc5195df3be3https://doi.org/10.3324/haematol.2020.251579
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection1997 · 865 citations
  2. 2Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase2010 · 64 citations
  3. 3Initial genome sequencing and analysis of multiple myeloma2011 · 1,464 citations
  4. 4Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients2016 · 93 citations
  5. 5EBV infection determines the immune hallmarks of plasmablastic lymphoma2018 · 31 citations